Proteomic analysis of propiconazole responses in mouse liver: Comparison of genomic and proteomic profiles

Journal of Proteome Research

Volumn 9, Issue 3, 2010, Pages 1268-1278

  Ortiz, Pedro A ^a   Bruno, Maribel E ^a   Moore, Tanya ^a   Nesnow, Stephen ^a   Winnik, Witold ^a   Ge, Yue ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Mouse; Networks; Pathways; Propiconazole; Protein expression; Proteomic

Indexed keywords

CELL NUCLEUS RECEPTOR; GLUTATHIONE TRANSFERASE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MYC PROTEIN; PROPICONAZOLE; PROTEASOME;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENOMICS; LIVER; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; XENOBIOTIC METABOLISM;

ANIMALS; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENOMICS; LIVER; MALE; MASS SPECTROMETRY; MICE; PROTEINS; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TRIAZOLES;

MUS;

EID: 77949865874     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr900755q     Document Type: Article

References (61)

1. Zarn, J. A.; Bruschweller, B. J.; Schlatter, J. R. Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 Sphademethylase and aromatase. Environ. Health Perspect. 2003, 111, 255-261.
2. INCHEM. Monograph 768. Propiconazole Part II Toxicology. In Pestidde Residues in Food: 1987 Evaluations, 1987; p 19.
3. U.S. Environmental Protection Agency. Reregistration Eligibility Decision (RED) for Propiconazole. http://www.epa.gov/oppsrrdl/REDs/propiconazole-red. pdf.
4. Allen, J. W.; Wolf, D. C.; George, M. H.; Hester, S. D.; Sun, G.; Thai, S. F.; Delker, D. A.; Moore, T.; Jones, C.; Nelson, G.; Roop, B. C.; Leavitt, S.; Winkfield, E.; Ward, W. O.; Nesnow, S. Toxicity profiles in mice treated with hepatotumorigenic and non-hepatotumorigenlc triazole conazole fungicides. Propiconazole, triadlmefon and myclobutanll. Toxicol. Pathol. 2006, 34, 853-862.
5. Chen, P. J.; Padgett, W. T.; Moore, T.; Winnik, W.; Lambert, G. R.; Thai, S. F.; Hester, S. D.; Nesnow, S. Three conazoles increase hepatic microsomal retinoic acid metabolism and decrease mouse hepatic retinoic acid levels in vivo. Toxicol. Appl. Pharmacol. 2009, 234, 143-155.
6. Sun, G.; Thai, S. F.; Tully, D. B.; Lambert, G. R.; Goetz, A. K.; Wolf, D. C.; Dix, D. J.; Nesnow, S. Propiconazole-induced cytochrome P450 gene expression and enzymatic activities in rat and mouse liver. Toxicol. Lett. 2005, 155, 277-287.
7. Ward, W. O.; Delker, D. A; Hester, S. D.; Thai, S. F.; Wolf, D. C.; Allen, J. W.; Nesnow, S. Transcriptional profiles in liver from mice treated with hepatotumorigenic and non-hepatotumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil. Toxicol. Pathol. 2006, 34, 863-878.
8. Nesnow, S.; Ward, W.; Moore, T.; Ren, H.; Hester, S. D. Discrimination of tumorigenic triazole conazoles from phenobarbital by transcriptional analyses of mouse liver gene expression. Toxicol. Sci. 2009, 110, 68-83.
9. Bruno, M.; Moore, T.; Nesnow, S.; Ge, Y. Protein carbonyl formation In response to propiconazole-induced oxidative stress. J. Proteome Res. 2009, 8, 2070-2078.
10. Ross, J. A.; Moore, T.; Leavitt, S. A In vivo mutagenicity of conazole fungicides correlates with tumorlgenicity. Mutaeenesis 2008, 24, 149-152.
11. Carmichael, N. G.; Enzmann, H.; Pate, I.; Waechter, F. The significance of mouse liver tumor formation for carcinogenic risk assessment: results and conclusions from a survey of ten years of testing by the agrochemical industry, Environ. Health. Perspect. 1997, 105, 1196-1203.
12. Kawahara, H.Cadrin, M.; French, S. W. Ethanol-induced phosphorylation of cytokeratin in cultured hepatocytes. Life Sci. 1990, 47, 859-863.
13. Merrick, B. A.; Bruno, M. E. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity. Curr. Qpin. Mol. Ther. 2004, 6, 600-607.
14. Pan, C.; Gnad, F.; Olsen, J. V.; Mann, M. Quantitative phosphoproteome analysis of a mouse liver cell line reveals specificity of phosphatase inhibitors. Proteomics 2008, 8, 4534-4546.
15. Sun, X.; Li, B.; Li, X.; Wang, Y.; Sun, G. F. Effects of sodium arsenite on catalase activity, gene and protein expression in HaCaT cells. Toxicol. in Vitro 2008, 20, 1139-1144
16. Kang, D. H.; Gho, Y. S.; Suh, M.; Chulhun Kang, C. Highly Sensitive and Fast Protein Detection with Coomassie Brilliant Blue in Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis. Bull. Korean Chem. Soc. 2002, 23, 1511-1512.
17. Ge, Y.; Molloy, M. P.; ChamberlSn, J. S.; Andrews, P. C. Differential expression of the skeletal muscle proteome in mdx mice at different ages. Electrophoresis 2004, 25, 2576-2585.
18. Rosenfeld, J.; Capdevielle, J.; Guillermot, J. C.; Ferrara, P. In-gel digestion of proteins for internal sequence analysis after one or two-dimensionS gel electrophoresis. Anal. Biochem. 1992, 203, 173-179.
19. Klenø, T. G.; Kiehr, B.; Baunsgaard, D.; Sidelmann, U. G. Combination of 'omics' data to investigate the mechanism(s) of hydrazineinduced hepatotoxicity in rats and to identify potential biomarkers. Biomarkers 2004, 9, 161-1138
20. Craig, A.; Sidaway, J.; Holmes, E.; Orton, T.; Jackson, D.; Rowlinson, R.; Nickson, J.; Tonge, R.; Wilson, I.; Nicholson, J. Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat. J Proteome Res. 2006, 7, 1586-1601.
21. Mijalski, T.; Harder, A.; Halder, T.; Kersfen, M.; Horsch, M.; Strom, T. M.; Liebscher, H. V.; Lottspeich, F.; de Angelis, M. H. Identification of coexpressed gene clusters in a comparative analysis of transcrlptome and proteome in mouse tissues. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 8621-8626.
22. Rignall, B.; Ittrich, C.; Krause, E.; Appel, K. E.; Buchmann, A.; Schwarz, M. Comparative transcriptome and proteome analysis of Ha-ras and B-raf mutated mouse liver tumors. J. Proteome Res. 2009, 8 (8), 3987-3994.
23. Nie, L.; Wu, G.; Culley, D. E.; Scholten, J. C.; Zhang, W. Integrative analysis of transcriptomic and proteomic data: challenges, solutions and applications. Crit. Rev. Biotechnol. 2007, 27, 63-75.
24. Cobbe, S. C.; Scobie, G. C.; Pohler, E.; Hayes, J. D.; Kernohan, N. M.; Dillon, J. F. Alteration of glutathione S-transferase levels in Barrett's metaplasia compared to normal oesophageal epithelium. Eur. J. Gastroenterol. Hepatol. 2003, 15, 41-47.
25. Sheweita, S. A.; Tilmisany, A K. Cancer and phase II drugmetabolizing enzymes. Curr. Drug Metab. 2003, 4, 45-58.
26. Nagaki, M.; Moriwaki, H. Transcription factor and hepatocyte differentiation. Hepatol. Res. 2008, 38, 961-969.
27. Zhong, W.; Mirkovitch, J.; Darnell, J. E., Jr. Tissue-specific regulation of mouse hepatocyte nuclear factor 4 expression. Mol. Cell. Biol. 1994, 14, 7276-7284.
28. Wang, H.; Maeschler, P.; Antinozzi, P. A.; Hagenfldt, K. A.; Wollheim, C. B. Hepatocyte nuclear factor 4 alpha regulates the expression of pancreatic beta-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion. J. Biol. Chem. 2000, 275, 35953-35959.
29. Leclerc, I.; Lenzner, C.; Gourdon, L.; Vaulont, S.; Kahn, A.; Viollet, B. Hepatocyte nuclear factor-4 alpha involved in type 1 maturityonset diabetes of the young is a novel target of AMP-activated protein kinase. Diabetes 2001, 50, 1515-1521.
30. BoJ, S. F.; Parrrizas, M.; Maestro, M. A.; Ferrer, J. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc. Nat. Acad. Sci. U.S.A. 2001, 98, 14481-14486.
31. Li, K.; Zhang, H.; Wang, Y.; Wang, Y.; Feng, M. Differential expression of HNF4 Spha isoforms in liver stem cells and hepatocytes. T. Cell Blochem. 2006, 99, 558-564.
32. Parvlz, F.; Matullo, C.; Garrison, W. D.; SavatskI, L.; Adamson, J. W.; Ning, G.; Kaestner, K. H.; Rossi, J. M.; Zaret, K. S.; Dune, S. A. Hepatocyte nuclear factor 4 alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet. 2003, 34, 292-296.
33. Xu, Z.; Tavares-Sanchez, O. L.; Li, Q.; Fernando, J.; Rodriguez, C. M.; Sfuder, E. J.; Pandak, W. M.; Hylemon, P. B.; Gil, G. Activation of bile acid biosynthesis by the p38 mitogen-activated protein kinase (MAPK): hepatocyte nuclear factor-4apha phosphorylation by the p38 MAPK is required for cholesterol 7apha-hydroxylase expression. J. Biol. Chem. 2007, 284, 24607-24614.
34. Tanos, T.; Marinissen, M. J.; Leskow, F. C.; Hochbaum, D.; Marfinetto, H.; Gutkind, J. S.; Coso, O. A. Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light. J. Biol. Chem. 2005, 280, 18842-18852.
35. Lopez-Bergami, P.; Huang, C.; Goydos, J. S.; Yip, D.; Bar-Eli, M.; Herlyn, M.; Smalley, K. S.; Mahale, A.; Eroshkin, A.; Aaronson, S.; Ronai, Z. Rewired ERK-JNK signSing pathways in melanoma. Cancer Cell 2007, 11, 447-460.
36. Ogura, Y.; Suruga, K.; Takase, S.; Goda, T. Developments changes of the expression of the genes regulated by retinoie acid in the small intestine of rats. Life Sci. 2005, 77, 2804-2813.
37. Abdelmegeed, M. A.; Moon, K. H.; Hardwick, J. P.; Gonzalez, F. J.; Song, B. J. Role of peroxisome proliferator-activated receptor-alpha in fasting-mediated oxidative stress. Free Radical Biol. Med. 2009, 47, 767-778.
38. Wang, J.; Maldonado, M. A. The ubiquitln-proteasome system and its role in inflammatory and autoimmune diseases. Cell Moll. Immunol. 2006, 4, 55-61.
39. Reinstein, E. Immunologic aspects of protein degradation by the ubiquitln-proteasome system, Isr. Med. Assoc. J. 2004, 6, 420-424.
40. Bochtler, M.; Ditzel, L.; Groll, M.; Hartmann, C.; Huber, R. The proteasome. Annu. Rev. Bionhys. Biomol. Struct. 1999, 28, 295-317.
41. Chen, H.; Liu, J.; Zhao, C. Q.; Diwan, B. A; Merrick, B. A.; Waalkes, M. P. Association of c-myc overexpression and hyperproliferation with arsenife-induced malignant transformation. Toxicol. Appl. Pharmacol. 2001, 175, 260-268.
42. Nilsson, J.A.; Cleveland, J. L. Myc pathways provoking cell suicide and cancer. Oncogene 2003, 22, 9007-9021.
43. Pelengaris, S.; Khan, M.; Evan, G. c-MYC: more than Just a matter of life and death. Nat. Rev. Cancer 2002, 2, 764-776.
44. Macarthur, M.; Georgina, L.; Hold, G. L.; El-Omar, E. M. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol.: Gastrointest. Liver Physiol. 2004, 286, G515-G520.
45. Zegura, B.; Lah, T. T.; Fillpic, M. Alteration of intracellular GSH levels and its role in microcystln-LR-induced DNA damage in human hepatoma HepG2 cells. Mutat. Res. 2006, 611, 25-33.
46. Cohen, J. I.; Roychowdhury, S.; DiBello, P. M.; Jacobsen, D. W.; Nagy, L. E. Exogenous thioredoxin prevents ethanol-induced oxidative damage and apoptosis in mouse liver. Hepatology 2009, 49, 1709-1717.
47. Liu, P. K.; Robertson, C. S.; Valadka, A. The association between neuronal nitric oxide synthase and neuronal sensitivity in the brain after brain injury. Ann. N.Y. Acad. Sci. 2002, 962, 226-241.
48. Wang, F.; Gao, F.; Lan, M.; Yuan, H.; Huang, Y.; Liu, J. Oxidative stress contributes to silica nanoparticle-induced cytotoxicity in human embryonic kidney cells. Toxicol, in Vitro 2009, 23, 808815.
49. Cederbaum, A. I.; Lu, Y.; Wu, D. Role of oxidative stress in Scoholinduced liver injury. Arch. Toxicol. 2009, 83, 519-548.
50. Barchowsky, A.; Munro, S. R.; Morana, S. J.; Vincenti, M. P.; Treadwell, M. Oxidant-sensitive and phosphorylation -dependent activation of NFkappa B and AI-1 in endothelial cells. Am. J. Physiol. 1995, 269, 829-836.
51. Rushmore, T. H.; Kong, A. N. Pharmacogenomics, regulation and signaling pathways of phase 1 and II drug metabolizing enzymes. Curr. Drug. Metab. 2002, 3, 481-490.
52. Chen, L.; Liu, L.; Huang, S. Cadmium activates the mitogenactivated protein kinase (MAPK) pathway via induction of reactive oxygen species and inhibiton of protein phosphatases 2A and 5. Free Radical Biol. Med. 2008, 45, 1035-1044.
53. Yamamoto, S.; Shlmizu, S.; Kiyonaka, S.; Takahashi, N.; Wajima, T.; Hara, Y.; Negoro, T.; Hiroi, T.; Kiuchi, Y.; Okada, T.; Kaneko, S.; Lange, I.; Fleig, A.; Penner, R.; Nishi, M.; Takeshima, H.; Mori, Y. Nat Med. TRPM2-mediated Ca2 + influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat. Med. 2008, 14, 738-747.
54. Yeldandi, A. V.; Rao, M. S.; Reddy, J. K. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat. Res. 2000, 448, 159-177.
55. Knight, T. R.; Supratim Choudhuri, S.; Klaassen, C. D. Induction of Hepatic Glutathione S-Transferases in Male Mice by Prototypes of Various Classes of Microsomal Enzyme Inducers. Toxicol. Sci. 2008, 106, 329-338.
56. Hayes, H. D.; Flanagan, J. U.; Jowsey, I. R. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 2005, 45, 51-88.
57. Mannervik, B.; Board, P. G.; Hayes, J. D.; Listowski, I.; Pearson, W. R. Nomenclature for mammalian soluble glutathione trasnferases. Methods Enzvmol. 2005, 401, 1-8.
58. Thomson, R. E.; Bigley, A. L.; Foster, J. R.; Jowsey, I. R.; Elcombe, C. R.; Orton, T. C.; Hayes, J. D. Tissue-specific expression and subcellular distribution of murine glutathione S-transferase class kappa. J. Histochem. Cytochem. 2009, 52, 653-662.
59. Shaw, M. The use of histological defined specific biomarkers in drug development with special reference to the glutathione s-transferases. Cancer Biomarkers 2005, 1, 69-74.
60. Vos, R. M.; Bladeren, P. J. Glutathione S-Transferases in relation to their role in the biotransformation of xenobiotics. Chem.-Biol. Interact. 1990, 75, 241-265.
61. Thyagaraju, K.; Hemavathi, B.; Vasundhara, K.; Rao, A. D.; Devi, K. N. Comparative study on glutathione transferases on rat brain and testis under the stress of phenobarbital and beta-methylcholanthrene. T. Zheitan Univ., Sci. B 2005, 6, 759-769.